Some problems in evaluating tumor responses in the clinical drug evaluation program.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005069:Evaluation Studies as Topic; D006801:Humans; D009369:Neoplasms / Q000473:pathology; D009378:Neoplasms, Multiple Primary
D000970:Antineoplastic Agents